A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases

Clinical trial NCT01378975 · COMPLETED

Trial details

NCT number: NCT01378975
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2011-07-01
Primary completion: 2015-07-01
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.